KOHLMEIER-DEGOS DISEASE

Clinical trials for KOHLMEIER-DEGOS DISEASE explained in plain language.

Never miss a new study

Get alerted when new KOHLMEIER-DEGOS DISEASE trials appear

Sign up with your email to follow new studies for KOHLMEIER-DEGOS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

One-Patient trial tests hope for devastating rare disease

Disease control Completed

This study tested an oral drug called ruxolitinib in a single adult patient with a rare, severe disease that damages blood vessels in the brain and spinal cord. The goal was to see if the drug could stop the disease from getting worse by preventing new brain lesions. The patient …

Matched conditions: KOHLMEIER-DEGOS DISEASE

Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

KOHLMEIER-DEGOS DISEASE

Get alerted when new KOHLMEIER-DEGOS DISEASE trials appear

One-Patient trial tests hope for devastating rare disease